In this study, we hypothesized that NK cells can further contribute to anti-tumor immunity through IFN-γ secretion by responding to myeloid-derived tumor-associated cells (TAC) and that such NK cell responses can be amplified by ADCC-triggering antibodies binding to TAC. Here, IFNG is linked to neoplasm.